JNK Pathway-Associated Phosphatase as a Serum Marker for Disease Activity and Treatment Outcome of Juvenile Idiopathic Arthritis.

In conclusion, serum JKAP is a potential biomarker for JIA activity and treatment response to a TNF inhibitor. PMID: 33441511 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33441511?dopt=Abstract

Source: The Tohoku Journal of Experimental Medicine - January 15, 2021 Category: Research Authors: Zhu S, Lv H, Luo Y, Huang Q, Shen J Tags: Tohoku J Exp Med Source Type: research